Physician

Ahmet Sinan Gursoy, M.D.

According to 2025 Medicare claims, Ahmet Gursoy, M.D. (NPI: 1174516546) practices interventional cardiology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is NAPLES INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, LLC (NPI: 1205891645; TIN: 201095753) and primary practice location at 34109-8143.

Gursoy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,175 traditional Medicare patients, billed 8,982 HCPCS/CPT codes, and received $930,462 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,057 prescription claims across 736 beneficiaries totaling $2,869,225 in drug costs, led by Vyndamax (Tafamidis). 2023 DME data shows 23 claims. Open Payments data shows 43 records totaling $822. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $874,892 to $2,869,225. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,307	15,512	$1,040,046
2016	2,058	11,817	$822,803
2017	2,027	11,542	$773,764
2018	1,959	11,889	$809,234
2019	2,023	14,341	$1,523,663
2020	1,775	13,481	$1,336,465
2021	1,647	14,243	$1,329,652
2022	1,515	12,698	$1,140,214
2023	1,299	11,607	$1,069,717
2024	1,175	8,982	$930,462

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	927	6,504	$874,892
2016	1,030	6,845	$1,054,498
2017	1,038	7,390	$1,699,880
2018	997	7,161	$2,120,237
2019	976	6,170	$1,970,974
2020	993	6,351	$2,129,438
2021	995	6,417	$2,111,269
2022	894	6,004	$2,436,083
2023	849	5,575	$2,717,979
2024	736	5,057	$2,869,225

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	23	$282
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	321	329	$151
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	640	1,071	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	787	1,330	$67
93280	Programming of dual lead pacemaker system	372	802	$59
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	388	541	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	31	1,154	$836,044
Entresto	Sacubitril/Valsartan	329	21,544	$452,563
Xarelto	Rivaroxaban	410	23,333	$426,332
Eliquis	Apixaban	277	18,490	$357,097
Jardiance	Empagliflozin	184	11,555	$218,375

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$822	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmet Sinan Gursoy, M.D.?

Tedicare shows public-source Medicare data for Ahmet Sinan Gursoy, M.D. (NPI 1174516546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmet Sinan Gursoy, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmet Sinan Gursoy, M.D.?

Ahmet Sinan Gursoy, M.D. is linked to NAPLES INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, LLC (billing NPI 1205891645) in the available physician profile data.

Does Ahmet Sinan Gursoy, M.D. have Open Payments data?

Ahmet Sinan Gursoy, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.